Found: 8
Select item for more details and to access through your institution.
Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 3, p. 231, doi. 10.1016/j.clpt.2005.11.002
- By:
- Publication type:
- Article
Cyclosporine markedly raises the plasma concentrations of repaglinide
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 4, p. 388, doi. 10.1016/j.clpt.2005.07.005
- By:
- Publication type:
- Article
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 6, p. 468, doi. 10.1016/j.clpt.2005.01.018
- By:
- Publication type:
- Article
Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 3, p. 217, doi. 10.1007/s00228-005-0093-8
- By:
- Publication type:
- Article
Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinide.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 58, n. 4, p. 390, doi. 10.1111/j.1365-2125.2004.02158.x
- By:
- Publication type:
- Article
The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 57, n. 4, p. 441, doi. 10.1046/j.1365-2125.2003.02027.x
- By:
- Publication type:
- Article
Differential Inhibition of Cytochrome P450 3A4, 3A5 and 3A7 by Five Human Immunodeficiency Virus (HIV) Protease Inhibitors in vitro.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2006, v. 98, n. 1, p. 79, doi. 10.1111/j.1742-7843.2006.pto_249.x
- By:
- Publication type:
- Article
Metabolism of Repaglinide by CYP2C8 and CYP3A4 in vitro: Effect of Fibrates and Rifampicin.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2005, v. 97, n. 4, p. 249, doi. 10.1111/j.1742-7843.2005.pto_157.x
- By:
- Publication type:
- Article